dpp-4 inhibitors and glp-1 agonists Were the original GLP-1s? How does sitagliptin work? DPP-4

This publication in no way absolves facilities of their responsibility for the appropriate orientation of healthcare professionals

In contrast, recommendations for treatment selection in the second-line setting have been outlined in international guidelines, such as the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) guidelines, which inform choice of treatment according to an individuals CV and chronic kidney disease (CKD) risk [15]

Euglycemic Ketoacidosis From Semaglutide in a Patient Without Diabetes

Diabetalogia 41 , 271278 (1998)

Another important factor in adopting these therapies is patient education

doi: 10.1038/s41574-019-0176-8 [DOI] [PubMed] [Google Scholar] 3.Rubino F, Puhl RM, Cummings DE, et al